Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ)

CAPS Rating: 2 out of 5

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.

Recs

0
Player Avatar modestus1 (< 20) Submitted: 1/13/2011 9:49:46 PM : Outperform Start Price: $22.63 JAZZ Score: +99.60

great products

Report this Post Reply

Featured Broker Partners


Advertisement